Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMDP) Payables (2016 - 2025)

Historic Payables for LifeMD (LFMDP) over the last 14 years, with Q3 2025 value amounting to $20.3 million.

  • LifeMD's Payables rose 2215.37% to $20.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.3 million, marking a year-over-year increase of 2215.37%. This contributed to the annual value of $16.8 million for FY2024, which is 3771.45% up from last year.
  • According to the latest figures from Q3 2025, LifeMD's Payables is $20.3 million, which was up 2215.37% from $25.1 million recorded in Q2 2025.
  • LifeMD's 5-year Payables high stood at $325.4 million for Q3 2023, and its period low was $9.5 million during Q1 2023.
  • Its 5-year average for Payables is $37.3 million, with a median of $15.8 million in 2024.
  • Per our database at Business Quant, LifeMD's Payables surged by 271156.86% in 2023 and then tumbled by 9488.53% in 2024.
  • Over the past 5 years, LifeMD's Payables (Quarter) stood at $10.0 million in 2021, then surged by 36.89% to $13.7 million in 2022, then fell by 10.9% to $12.2 million in 2023, then surged by 37.71% to $16.8 million in 2024, then increased by 21.12% to $20.3 million in 2025.
  • Its Payables was $20.3 million in Q3 2025, compared to $25.1 million in Q2 2025 and $16.5 million in Q1 2025.